Vimarsana
Biggest News Aggregation in the World

Page 26 - Xtend News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xtend. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xtend Today - Breaking & Trending Today

DEA temporarily extends telehealth prescribing flexibilities - Vimarsana News

DEA temporarily extends telehealth prescribing flexibilities

The Drug Enforcement Agency is looking to temporarily extend the flexibility of prescribing controlled substances via telemedicine beyond the COVID-19 public health emergency, The Washington Post reported May 3. 

Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma - Vimarsana News

Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma

Results Confirm and Extend Response Results from Phase 3 FLASH Study PRINCETON, N.J., May 4, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and... | May 4, 2023

The Coretec Group Files a Provisional Patent for Improved Silicon-Based Battery Anode Development - Vimarsana News

The Coretec Group Files a Provisional Patent for Improved Silicon-Based Battery Anode Development

Company scientists have created three distinct strategies to extend the life and increase the density capabilities of lithium-ion batteries, with an emphasis on manufacturing scalabilityANN ARBOR,... | May 4, 2023

Senators urge DEA to permanently extend telehealth prescribing flexibilities - Vimarsana News

Senators urge DEA to permanently extend telehealth prescribing flexibilities

Six senators, led by Sen. Edward Markey, D-Mass., have urged the Drug Enforcement Agency to permanently extend flexibilities that allow physicians to prescribe controlled substances via telemedicine without an in-person evaluation.

Analysis-Investors see big Novo Nordisk stock boost if obesity drug shows heart benefit - Vimarsana News

Analysis-Investors see big Novo Nordisk stock boost if obesity drug shows heart benefit

Positive trial data showing Novo Nordisk's obesity drug helps save and extend lives, not just lose weight, could propel Europe's best-performing stock even higher, according to 10 investors and... | May 3, 2023